mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
Authors
Keywords
-
Journal
Cell and Bioscience
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-10
DOI
10.1186/s13578-020-00396-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- piRNAs: biogenesis and their potential roles in cancer
- (2020) Binghong Guo et al. CANCER AND METASTASIS REVIEWS
- Microsatellite instability: a review of what the oncologist should know
- (2020) Kai Li et al. Cancer Cell International
- GWAS in cancer: progress and challenges
- (2020) Baiqiang Liang et al. MOLECULAR GENETICS AND GENOMICS
- RNA-based pharmacotherapy for tumors: From bench to clinic and back
- (2020) Xiangping Liang et al. BIOMEDICINE & PHARMACOTHERAPY
- Cancer immunotherapy: Pros, cons and beyond
- (2020) Shuzhen Tan et al. BIOMEDICINE & PHARMACOTHERAPY
- Loss of BCAA Catabolism during Carcinogenesis Enhances mTORC1 Activity and Promotes Tumor Development and Progression
- (2019) Russell E. Ericksen et al. Cell Metabolism
- Decreased incidence of Kaposi sarcoma after kidney transplant in Italy and role of mTOR-inhibitors: 1997-2016
- (2019) Pierluca Piselli et al. INTERNATIONAL JOURNAL OF CANCER
- The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2
- (2019) Joanna R. Kovalski et al. MOLECULAR CELL
- Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma
- (2019) Yixin Yang et al. Cell Death & Disease
- GLI1 overexpression promotes gastric cancer cell proliferation and migration and induces drug resistance by combining with the AKT-mTOR pathway
- (2019) Yizhou Yao et al. BIOMEDICINE & PHARMACOTHERAPY
- IL‐8 protects prostate cancer cells from GSK‐3β‐induced oxidative stress by activating the mTOR signaling pathway
- (2019) Yi Sun et al. PROSTATE
- mTOR Inhibitors Can Enhance the Anti-Tumor Effects of DNA Vaccines through Modulating Dendritic Cell Function in the Tumor Microenvironment
- (2019) Yu-Li Chen et al. Cancers
- YAP promotes multi-drug resistance and inhibits autophagy-related cell death in hepatocellular carcinoma via the RAC1-ROS-mTOR pathway
- (2019) Yuan Zhou et al. Cancer Cell International
- PTEN expression and mutations in TSC1 , TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma
- (2019) Juan M. Roldan‐Romero et al. INTERNATIONAL JOURNAL OF CANCER
- The single-cell sequencing: new developments and medical applications
- (2019) Xiaoning Tang et al. Cell and Bioscience
- Metformin represses the pathophysiology of AAA by suppressing the activation of PI3K/AKT/mTOR/autophagy pathway in ApoE−/− mice
- (2019) Zhu Wang et al. Cell and Bioscience
- Is Dual mTORC1 and mTORC2 Therapeutic Blockade Clinically Feasible in Cancer?
- (2019) Nisha Unni et al. JAMA Oncology
- Two novel TSC2 mutations in renal epithelioid angiomyolipoma sensitive to everolimus
- (2019) Tao Wang et al. CANCER BIOLOGY & THERAPY
- Transcriptome analysis reveals an important candidate gene involved in both nodal metastasis and prognosis in lung adenocarcinoma
- (2019) Xiao Zhu et al. Cell and Bioscience
- Transcriptional regulation in model organisms: recent progress and clinical implications
- (2019) Jiaqi Tang et al. Open Biology
- The cancer exosomes: Clinical implications, applications and challenges
- (2019) Zhenye Tang et al. INTERNATIONAL JOURNAL OF CANCER
- Circular RNAs: The star molecules in cancer
- (2019) Jianhong Liu et al. MOLECULAR ASPECTS OF MEDICINE
- Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study
- (2018) Glenn J. Hanna et al. CLINICAL CANCER RESEARCH
- A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer
- (2018) Johanna C. Bendell et al. CLINICAL CANCER RESEARCH
- Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma
- (2018) Joseph J. Caumanns et al. CLINICAL CANCER RESEARCH
- Predictive biomarkers of endometrial cancer response: Results from NRG Oncology/Gynecologic Oncology Group study 86P
- (2018) D.A. Levine et al. GYNECOLOGIC ONCOLOGY
- Significance and mechanism of androgen receptor overexpression and androgen receptor/mechanistic target of rapamycin cross-talk in hepatocellular carcinoma
- (2018) Hong Zhang et al. HEPATOLOGY
- Activation of WNT/β-catenin signaling results in resistance to a dual PI3K/mTOR inhibitor in colorectal cancer cells harboring PIK3CA mutations
- (2018) Ye-Lim Park et al. INTERNATIONAL JOURNAL OF CANCER
- Biallelic TSC2 Mutations in a Patient With Chromophobe Renal Cell Carcinoma Showing Extraordinary Response to Temsirolimus
- (2018) Pablo Maroto et al. Journal of the National Comprehensive Cancer Network
- The mTOR–S6K pathway links growth signalling to DNA damage response by targeting RNF168
- (2018) Xiaoduo Xie et al. NATURE CELL BIOLOGY
- mTOR Inhibition via Displacement of Phosphatidic Acid Induces Enhanced Cytotoxicity Specifically in Cancer Cells
- (2018) Tra-Ly Nguyen et al. CANCER RESEARCH
- Downregulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis
- (2018) Ting Tao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Ubiquitination of Rheb governs growth factor-induced mTORC1 activation
- (2018) Lu Deng et al. CELL RESEARCH
- Crosstalks between mTORC1 and mTORC2 variagate cytokine signaling to control NK maturation and effector function
- (2018) Fangjie Wang et al. Nature Communications
- UCP2 inhibition induces ROS/Akt/mTOR axis: Role of GAPDH nuclear translocation in genipin/everolimus anticancer synergism
- (2017) Ilaria Dando et al. FREE RADICAL BIOLOGY AND MEDICINE
- Roquin Suppresses the PI3K-mTOR Signaling Pathway to Inhibit T Helper Cell Differentiation and Conversion of Treg to Tfr Cells
- (2017) Katharina Essig et al. IMMUNITY
- Co-occurring Genomic Alterations and Association With Progression-Free Survival in BRAFV600-Mutated Nonmelanoma Tumors
- (2017) Shiraj Sen et al. JNCI-Journal of the National Cancer Institute
- mTOR Kinase Inhibition Effectively Decreases Progression of a Subset of Neuroendocrine Tumors that Progress on Rapalog Therapy and Delays Cardiac Impairment
- (2017) Melissa A. Orr-Asman et al. MOLECULAR CANCER THERAPEUTICS
- TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling
- (2017) Bin Wang et al. NATURE
- mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy
- (2017) Kara N. Goldman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcriptional activation of RagD GTPase controls mTORC1 and promotes cancer growth
- (2017) Chiara Di Malta et al. SCIENCE
- Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade
- (2017) Kei Ishibashi et al. Oncotarget
- Co-occurring Genomic Alterations and Association With Progression-Free Survival in BRAFV600-Mutated Nonmelanoma Tumors
- (2017) Shiraj Sen et al. JNCI-Journal of the National Cancer Institute
- Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
- (2016) D. J. Kwiatkowski et al. CLINICAL CANCER RESEARCH
- TSC1/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication
- (2016) Daniel W H Ho et al. GUT
- Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma
- (2016) Agnieszka Korfel et al. JOURNAL OF CLINICAL ONCOLOGY
- Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
- (2016) Vanessa S. Rodrik-Outmezguine et al. NATURE
- MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma
- (2015) S. Mohan et al. CLINICAL CANCER RESEARCH
- mTORC2 promotes cell survival through c-Myc–dependent up-regulation of E2F1
- (2015) Zhipeng Zou et al. JOURNAL OF CELL BIOLOGY
- A Novel Dual AMPK Activator/mTOR Inhibitor Inhibits Thyroid Cancer Cell Growth
- (2015) Robert L. Plews et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation
- (2015) Kristen N. Pollizzi et al. JOURNAL OF CLINICAL INVESTIGATION
- Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
- (2015) Robert J Motzer et al. LANCET ONCOLOGY
- Therapy-induced tumour secretomes promote resistance and tumour progression
- (2015) Anna C. Obenauf et al. NATURE
- Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP
- (2015) S J H Ricoult et al. ONCOGENE
- Targeting mTOR dependency in pancreatic cancer
- (2014) Douglas C Morran et al. GUT
- HSP90 inhibitor AUY922 abrogates up-regulation of RTKs by mTOR inhibitor AZD8055 and potentiates its antiproliferative activity in human breast cancer
- (2014) Si-Meng Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer
- (2014) Hui Jun Lim et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- 9q33.3, A Stress-Related Chromosome Region, Contributes to Reducing Lung Squamous Cell Carcinoma Risk
- (2014) Qin Xiao et al. Journal of Thoracic Oncology
- Mutation analysis of key genes in RAS/RAF and PI3K/PTEN pathways in Chinese patients with hepatocellular carcinoma
- (2014) WENMIN HOU et al. Oncology Letters
- The rs391957 variant cis-regulating oncogene GRP78 expression contributes to the risk of hepatocellular carcinoma
- (2013) Xiao Zhu et al. CARCINOGENESIS
- The translational landscape of mTOR signalling steers cancer initiation and metastasis
- (2012) Andrew C. Hsieh et al. NATURE
- An Intronic Polymorphism in GRP78 Improves Chemotherapeutic Prediction in Non-small Cell Lung Cancer
- (2011) Xiao Zhu et al. CHEST
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Dissecting the role of mTOR: Lessons from mTOR inhibitors
- (2009) Ryan J.O. Dowling et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- TOR-dependent control of autophagy: biting the hand that feeds
- (2009) Thomas P Neufeld CURRENT OPINION IN CELL BIOLOGY
- Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9
- (2009) Jing-song Chen et al. HEPATOLOGY RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More